Spring direct naar de hoofdnavigatie of de inhoud
‘Investing that little extra time and effort in IP at the right moment makes your technology go further.’
Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

Continue reading

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)

Education

  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)

Directories

  • “Focusing her practice on the pharmaceutical and chemistry sectors, Jennifer Ebner von Eschenbach is a savvy strategist with three decades of wisdom up her sleeve. She adeptly navigates the prosecution landscape to ensure all areas of her patrons’ innovations are robustly protected” (IAM Patent 1000, 2024)
  • “Chemistry expert Jennifer Ebner von Eschenbach gives added heft to the firm’s life science specialisation. Detail oriented and strategic, she delivers commercially astute and technically deft prosecution to her following. With over three decades of experience in the profession, Ebner is a smart choice for business-critical portfolios across a wide array of chemical and pharmaceutical innovations” (IAM Patent 1000, 2023)
  • Recommended Individual (IAM Patent 1000, 2023, 2024)

Publications

  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988

Languages

  • German
  • English

Also see these experts

Frits Schut

Frits Schut

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Annemiek Tepper

Annemiek Tepper

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

What about your ‘T & C’?

The importance of terms and conditions is often underestimated – writing the two words in full is sometimes even too much. “Who reads them at all?”, ‘We don’t even know what’s in them ourselves’, ‘We rarely fall back on them’ and ‘Why would we want to put general terms and conditions forward if the cooperation […]Continue reading

Upcoming decision on legal criterion for ‘novelty’

One of the most important requirements for obtaining a patent on a product in Europe is that the product is novel. That means that before the day on which the patent application was filed, the product was not yet available to the public in any way.Continue reading

An update on the unitary patent system

As of 1 June 2023, the European Patent Office (EPO) offers the possibility to register a granted European patent as a unitary patent. This unitary patent has effect in 18 European Union (EU) member states, representing 80% of the GDP of the EU. Before its start, it was uncertain if patentees would readily embrace the […]Continue reading

Events

NCCC 2025

Hotel NH Noordwijk Conference Centre Leeuwenhorst, Langelaan, Noordwijkerhout

The 26th edition of the NCCC (Netherlands Catalysis and Chemistry Conference) takes place from Monday 10 to Wednesday 12 March in Noordwijkerhout.

Continue reading

Beta Business Days 2025

Martiniplaza, Leonard Springerlaan, Groningen, Netherlands

The Beta Business Days is a two-day event aimed at establishing contacts between companies and ambitious students from Groningen.

Continue reading